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Evaluation of the relationship between obstructive sleep apnea
syndrome severity and cephalometric and clinical variables
Süleyman Hakan TUNA1, Önder ÖZTÜRK2, Muhammet Hakan TÜRKKAHRAMAN3, Hüseyin ALKIŞ3,
Hüseyin Avni BALCIOĞLU4, Ahmet AKKAYA2

Aim: To evaluate the cephalometric features of patients with obstructive sleep apnea syndrome (OSAS) and to elucidate
the relationship between the severity of OSAS and cephalometric and clinical variables.
Materials and methods: Ninety-three patients (71M/22W) with OSAS were classified into 3 subgroups according to
the apnea-hypopnea index (AHI). Various cephalometric and clinical measurements were carried out for all patients.
Results: Inferior airway space (IAS), maximum soft palate thickness (MSPT), SNGoGn°, and distance of hyoid bone
to mandibular plane (Hy-MPPerp) were found to be higher in severe OSAS for both sexes. Middle airway space, IAS,
MSPT, and Hy-MPPerp were correlated positively with AHI; however, superior airway space (SAS) was correlated
negatively. In the stepwise regression analysis, mean SaO2, neck circumferences for men, and mean SaO2 and uvula
length (PNS-PA) for women were included in the model to estimate AHI properties.
Conclusion: The values of IAS, MSPT, SNGoGn°, and Hy-MPPerp showed a tendency to increase with the severity of
OSAS. Although the cephalometric variables used to estimate OSAS severity had no effect in men, PNS-PA was found
to have an influence in women. However, it is thought that it is difficult to use cephalometric variables to estimate AHI
severity in both sexes.
Key words: Cephalometry, OSAS, AHI, polysomnography

Introduction
Obstructive sleep apnea syndrome (OSAS) is a
common condition affecting at least 2% of adult
women and 4% of adult men (1). It is characterized
by loud snoring and periodic breathing with
repetitive apneas, hypopneas, and arousals leading to
fragmented sleep and excessive daytime sleepiness.
Patients with OSAS have significantly impaired
quality of life and social functioning and a high
prevalence of minor psychiatric morbidity. There is
some evidence that it is a progressive disorder and
also an independent risk factor for cardiovascular

morbidity and mortality (2-4). Although a higher
mortality rate has been found in patients with severe
OSAS than in those with mild-to-moderate OSAS,
most of the patients (93% of women and 82% of men)
with moderate-to-severe OSAS remain undiagnosed
(5). As it is a serious condition and a progressive
disease, the early diagnosis of OSAS is important
(6). The gold standard diagnostic method for this
syndrome is polysomnography (7), but it is a costly
and labor-intensive technique that is uncomfortable
for the patient and not available in all centers.
Furthermore, protracted waiting lists for performing
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this method result in diagnosis and treatment delays
for patients with important symptoms of OSAS (8).
The importance of the morphology of the upper
airway (soft palate, uvula, and tongue) and the
craniofacial morphology in the pathogenesis of
OSAS is widely acknowledged (8). Several methods
exploiting advanced technologies have been used to
evaluate the anatomic characteristics of the upper
airway and the craniofacial structures that might
predict OSAS and determine the sites of obstruction
(9,10). However, the traditional cephalometric
method has been the most practical (10). Lateral
cephalometry is a readily available, inexpensive,
and reliable technique for assessing the pharyngeal
airways, whereby details of skeletal and soft tissue
structures can be accurately measured and compared
with extensive normative data (11). In addition to
identifying cranio-facial anomalies, cephalometric
measurements can also be used to quantify treatment
options, such as surgery, appliances, or continuous
positive airway pressure for OSAS (12,13).
The aims of this study were to evaluate the
cephalometric features of patients with OSAS and to
elucidate the relationship between severity of OSAS
and cephalometric and clinical variables.
Materials and methods
Patients and polysomnography
Ninety-three Caucasian adults (71 men and 22
women) who had been referred to the sleep clinic
because of suspected OSAS were recruited. All
patients were examined by 1 of 2 pulmonologists
experienced in sleep medicine. The patients were
recruited on the basis of the following inclusion
criteria: dentate in both jaws, between 35 and 65 years
of age, AHI > 5 events per hour, and no apparent
craniofacial deformities. The patients were excluded
if there was any previous history of pharyngeal
surgery, orthognathic surgery, or poor general dental
health. All patients gave informed consent before
participating in the study.
On the evening of the sleep study, a comprehensive
physical examination that included anthropometric
measurements such as height and weight for
the calculation of body mass index (BMI), neck
circumference [(NC) at the level of the cricothyroid
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membrane], and waist circumference [(WC) at the
level of the umbilicus] was performed. The patients
filled out a self-administered questionnaire that
included questions about the symptoms normally
associated with OSAS (snoring, presence of
apneas, sleep quality, and daytime somnolence).
In addition, the Epworth sleepiness scale (ESS),
previously translated into Turkish and validated, was
administered (14). The sleep functions of patients
were evaluated using overnight polysomnography
(Compumedics, 44 channels E series, Australia).
Oronasal flow was measured using a nasal cannula,
and thoracic and abdominal movements were
detected using 2 piezoelectric belts. A pulse
oximeter continuously recorded digital oximetry.
A desaturation event (dip) was considered when
oxygen saturation (SaO2) diminished by 3% or
greater in relation to the baseline. The sleep studies
were staged according to the Rechtschaffen and Kales
(15) criteria by 2 trained sleep clinicians who were
blind to the clinical characteristics of each patient.
Apnea was defined as the cessation of airflow for
10 s or longer. Hypopnea was defined as an airflow
reduction of at least 50% over preceding epochs
or an amplitude reduction of at least 50% of the
thoracoabdominal belts (also compared to prior
epochs), together with the presence of either arterial
oxygen desaturation equal to or greater than 3% or an
arousal. The patients with an AHI of 5 or higher were
considered to have OSAS. They were divided into 3
groups according to the AHI values (16): Group I
(mild OSAS) with AHI 5-15/h included 24 patients
(18 men, 6 women); Group II (moderate OSAS)
with AHI 15-30/h included 35 patients (26 men, 9
women); and Group III (severe OSAS) with AHI >
30/h included 34 patients (27 men, 7 women) (Table
1).
Cephalometric analysis
A standard cephalometric radiograph was obtained
for each subject with the teeth in centric occlusion
and the Frankfort horizontal plane parallel to the
floor at the end of the expiration phase and without
swallowing. Each radiograph was scanned into
digital format at 300 dpi resolution, stored in TIFF
format, and transferred to Dolphin imaging software
(Dolphin, Chatsworth, CA, USA) for digitization of
landmarks. Each image was digitally traced twice
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Table 1. The demographic characteristics, polysomnographic and cephalometric data of all patients. Values are expressed as mean ± SD.
Men (n = 71)

Women (n = 22)
OSAS mean ± SE

Demographic
features
Mild
(n = 18)

Moderate
(n = 26)

Severe
(n = 27)

Mild
(n = 6)

Moderate
(n = 9)

Severe
(n = 7)

Age

47.22 ± 2.66

49.85 ± 1.49

48.56 ± 2.01

48.83 ± 3.11

51.78 ± 1.05

47.71 ± 3.29

Height

172.28 ± 1.21

170.42 ± 0.79

168.11 ± 1.66

158.67 ± 2.67

158.67 ± 1.17

161.14 ± 0.94

Weight

80.89 ± 2.67

85.69 ± 2.45

97.44 ± 3.52

76.17 ± 6.25

88.78 ± 3.52

83.71 ± 6.30

BMI

27.27 ± 0.89

29.46 ± 0.72

34.65 ± 1.36

30.07 ± 2.55

35.33 ± 1.53

32.11 ± 2.18

NC

39.39 ± 0.59

39.73 ± 0.42

42.07 ± 0.60

35.17 ± 1.11

35.33 ± 0.73

35.86 ± 1.26

WC

96.11 ± 2.83

97.58 ± 3.09

108.85 ± 2.51

96.67 ± 8.43

107.78 ± 64.9

104.86 ± 4.03

Polysomnographic data
AHI

7.87 ± 0.63

21.33 ± 0.79

63.04 ± 4.57

7.62 ± 0.95

19.70 ± 1.70

62.59 ± 8.07

Arousal index

13.11 ± 1.90

20.05 ± 2.79

32.01 ± 3.47

16.30 ± 3.86

10.33 ± 1.85

16.30 ± 4.59

Awake mean SaO2

94.39 ± 0.43

93.69 ± 0.33

92.93 ± 0.34

94.50 ± 0.67

93.89 ± 0.39

94.57 ± 0.48

Lowest SaO2

85.89 ± 0.75

79.65 ± 1.32

73.52 ± 1.89

84.67 ± 1.26

79.00 ± 1.92

69.57 ± 4.04

Mean SaO2 Des.%

4.00 ± 0.19

5.15 ± 0.35

8.37 ± 0.74

4.33 ± 0.21

4.78 ± 0.43

9.86 ± 2.32

ESS

3.78 ± 0.71

6.35 ± 0.92

8.04 ± 0.91

2.17 ± 1.08

3.44 ± 0.73

6.00 ± 2.00

IAS

10.54 ± 0.77

12.22 ± 0.73

13.82 ± 0.65

11.00 ± 1.21

12.10 ± 1.07

13.93 ± 1.61

SAS

19.54 ± 0.66

20.52 ± 0.69

17.53 ± 0.90

19.57 ± 0.86

18.73 ± 0.65

17.01 ± 0.85

MAS

7.43 ± 0.59

7.86 ± 0.47

9.28 ± 0.57

7.13 ± 0.83

8.16 ± 0.80

8.06 ± 1.17

MSPT

12.06 ± 0.53

12.82 ± 0.29

13.73 ± 0.52

10.42 ± 0.45

11.04 ± 0.47

11.41 ± 0.74

SNGoGn°

31.18 ± 1.56

31.03 ± 1.26

32.47 ± 1.16

28.72 ± 3.67

29.39 ± 1.54

35.39 ± 3.03

Go-Gn

88.21 ± 1.73

93.35 ± 1.04

90.42 ± 0.95

88.15 ± 1.67

86.28 ± 2.09

84.03 ± 2.41

ANB°

3.73 ± 0.52

3.77 ± 0.61

3.20 ± 0.40

4.33 ± 1.34

2.21 ± 0.65

4.13 ± 0.78

Ant. FH

137.01 ± 1.67

139.24 ± 1.56

142.36 ± 1.37

129.10 ± 2.19

127.20 ± 1.76

128.87 ± 2.91

Post. FH

68.94 ± 1.36

73.96 ± 2.56

72.56 ± 2.37

67.65 ± 3.26

69.13 ± 2.53

68.66 ± 3.59

Hy-MPPerp

22.99 ± 1.21

20.32 ± 1.31

24.37 ± 1.23

19.12 ± 1.40

16.73 ± 1.73

20.81 ± 2.72

PNS-PA

43.37 ± 1.16

44.51 ± 1.01

43.41 ± 1.17

41.47 ± 1.42

39.70 ± 1.83

36.74 ± 1.41

ANS-Me

76.52 ± 1.80

78.52 ± 1.25

78.64 ± 1.16

70.18 ± 1.27

71.19 ± 1.32

70.61 ± 1.50

Cephalometric data

by the same investigator (H.A.). In each lateral
cephalogram, 14 landmark points were identified
(Figure 1). Upper airway space was measured
at 3 different levels (15); the angles and linear
measurements are given in Figure 2.

Statistical analysis
All statistical analyses were performed using SPSS
(version 16.0, SPSS, Chicago, IL, USA). The results
of the study were evaluated using factorial design
ANOVA. The sex factor consisted of 2 levels and
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Figure 1. Landmarks on lateral cephalograms: S: sella; N: nasion; Or: orbitale; ANS: anterior nasal spine; PNS: posterior nasal spine; A:
point A; B: point B; G: gnathion; Me: menton; Go: gonion; Hy: hyoid bone; PA: tip of uvula; Po: porion; Ba: basion.
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Figure 2. Linear and angle measurements on lateral cephalograms: 1: inferior airway space (IAS); 2: middle airway space (MAS); 3:
superior airway space (SAS); 4: maximum soft palate thickness (MSPT); 5: SNGoGn°; 6: mandibular body length (Go-Gn);
7: ANB°; 8: anterior face height (Ant. FH); 9: posterior face height (Post. FH) 10: distance of hyoid bone to mandibular
plane (Hy-MPPerp); 11: uvula length (PNS-PA); 12: lower face height (ANS-Me); 13: sella-nasion plane (SN); 14: Frankfort
horizontal plane (FH); 15: mandibular plane (MP).
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the diagnostic factor had 3 levels (mild, moderate,
and severe). Tukey’s test was used to evaluate the
differences between groups. Kruskal-Wallis and
Mann-Whitney U tests were used to evaluate the
parameters [arousal index, oxygen saturation
(mean and minimum), height, MSPT, Post. FH,
ESS], which did not provide the precondition of
parametric tests. The Bonferroni-Dunn method
was used, finding statistically significant differences
for Kruskal-Wallis. The correlation coefficient was
used to examine positive relations between the
study parameters. The correlation coefficients were
measured and interpreted for each sex and diagnosis.
Stepwise regression analysis was done using AHI as
a dependent variable. The diagnoses done using AHI
were studied using discriminant analysis with other
parameters.

Wallis test when we compared the means of diagnostic
factor (P < 0.001). The differences between the
severity of OSAS after the Bonferroni-Dunn test are
shown in Table 3. For the arousal index for women,
the difference between the rank means of diagnosis
was not statistically significant.

Results

The difference in the diagnostic rank means
was statistically significant in the comparison of
diagnostic level means using Kruskal-Wallis for
the mean SaO2 desaturation of men and women (P
< 0.001 and P < 0.05, respectively). The differences
between the severity of OSAS after BonferroniDunn are shown in Table 3. However, there was no
statistically significant difference between men and
women for mild, moderate, or severe OSAS.

The demographic features and polysomnographic
and cephalometric data of patients with OSAS are
given in Table 1.
The sex/diagnosis interaction and the differences
between sex factor means and diagnostic factor means
were not statistically significant for the awake mean
SaO2%, waist circumference, neck circumference,
MAS, Go-Gn, Ant. FH, Hy-MPPerp, PNS-PA, ANSMe, SNGoGn°, or ANB°. The differences between
the mean of neck circumference, Go-Gn, ANS-Me,
Ant. FH (P < 0.01), Hy-MPPerp (P < 0.05), and PNSPA (P < 0.001) of men and women were statistically
significant. The sex/diagnosis interaction and the
differences between the level of sex factor means
were not statistically significant for weight, IAS, or
SAS. However, the differences between the diagnostic
factor means were significant (P < 0.05) (Table 2).
The sex/diagnosis interaction for BMI was found to
be statistically significant (P < 0.05). The differences
between the mean of BMI varied due to the severity
of OSAS. Tukey’s test was performed, and the results
are shown in Table 2.
The mean level of arousal index varied due to the
severity of OSAS, and the difference was significant
(Kruskal-Wallis, P < 0.001). The difference between
the rank means of diagnosis was statistically
significant for arousal index of men for the Kruskal-

The rank means of men and women were
evaluated for arousal index for mild OSAS. It was
not statistically significant for mild OSAS, but was
significant for moderate and severe OSAS (MannWhitney U, P < 0.05).
The rank means of diagnosis were statistically
significant in the comparison of diagnostic level
means using Kruskal-Wallis for the lowest SaO2 of
men and women (P < 0.05 and P < 0.01, respectively).
However, there was no statistically significant
difference between men and women for mild,
moderate, or severe OSAS.

The difference in the diagnostic rank means
was statistically significant in the comparison of
diagnostic level means using Kruskal-Wallis for the
height of men (P < 0.05). The differences between the
severity of OSAS after the Bonferroni-Dunn test are
shown in Table 3. The difference between the rank
means of men and women for height was statistically
significant for mild, moderate, and severe OSAS
(Mann-Whitney U, P < 0.001, P < 0.001 and P < 0.05,
respectively). However, the difference between the
rank means of diagnosis was not significant in the
comparison of diagnostic level means using KruskalWallis for the height of women.
The difference of the diagnostic rank means was
not significant in the comparison of diagnostic level
means using Kruskal-Wallis for the MSPT of men and
women. For mild OSAS, the difference between the
rank means of men and women was not significant
(Mann-Whitney U, P > 0.05), but, for moderate
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Table 2. Sex × diagnosis interaction table showing the differences that were statistically significant.
OSAS (mean ± SE)
´Parameters

BMI

Weight

NC

IAS

SAS

Go-Gn

Ant. FH

Hy-MPPerp

PNS-PA

ANS-Me

Sex

Total
Mild

Moderate

Severe

Men

27.27bA ± 1.25

29.46bB ± 1.04

34.65aA ± 1.02

30.46 ± 0.64

Women

30.07aA ± 2.16

35.33aA ± 1.76

32.11aA ± 2.00

32.51 ± 1.14

Total

28.67 ± 1.25

32.40 ± 1.02

33.38 ± 1.12

Men

80.89 ± 3.44

85.70 ± 2.86

97.44 ± 2.81

88.01 ± 1.76

Women

76.17 ± 5.96

88.78 ± 4.86

83.71 ± 5.51

82.89 ± 3.15

Total

78.53b ± 3.44

87.24ab ± 2.82

90.58a ± 3.09

Men

39.39 ± 0.63

39.731 ± 0.524

42.074 ± 0.514

40.39A ± 0.322

Women

35.17 ± 0.09

35.33 ± 0.89

35.86 ± 1.01

35.45B ± 0.58

Total

37.28 ± 0.63

37.53 ± 0.51

38.97 ± 0.57

Men

10.54 ± 0.82

12.22 ± 0.68

13.82 ± 0.67

12.19 ± 0.42

Women

11.00 ± 1.42

12.10 ± 1.16

13.93 ± 1.32

12.34 ± 0.75

Total

10.77b ± 0.82

12.16ab ± 0.67

13.87a ± 0.74

Men

19.54 ± 0.84

20.52 ± 0.70

17.53 ± 0.53

19.19 ± 0.43

Women

19.57 ± 1.45

18.73 ± 1.18

17.01 ± 1.34

18.44 ± 0.77

Total

19.55ab ± 0.84

19.62a ± 0.69

17.27b ± 0.75

Men

88.21 ± 1.36

93.35 ± 1.13

90.42 ± 1.11

90.66 ± 0.70

Women

88.15 ± 2.36

86.28 ± 1.92

84.03 ± 2.20

86.15 ± 1.25

Total

88.18 ± 1.36

89.82 ± 1.12

87.22 ± 1.22

Men

137.01 ± 1.70

139.24 ± 1.41

142.36 ± 1.38

139.54A ± 0.88

Women

128.10 ± 2.93

127.20 ± 2.40

128.87 ± 2.71

128.06B ± 1.55

Total

132.56 ± 1.70

133.22 ± 1.39

135.62 ± 1.52

Men

22.99 ± 1.44

20.32 ± 1.20

24.37 ± 1.20

22.56A ± 0.74

Women

19.12 ± 2.72

16.73 ± 2.03

20.81 ± 2.30

18.89B ± 1.37

Total

21.05 ± 1.54

18.53 ± 1.18

22.59 ± 1.29

Men

43.37 ± 1.24

44.51 ± 1.03

43.41 ± 1.02

43.76A ± 0.64

Women

41.47 ± 2.15

39.70 ± 1.76

36.74 ± 1.99

39.30B ± 1.14

Total

42.42 ± 1.24

42.11 ± 1.02

40.08 ± 1.12

Men

76.52 ± 1.44

78.52 ± 1.20

78.64 ± 1.17

77.89A ± 0.73

Women

70.18 ± 2.48

71.19 ± 2.03

70.61 ± 2.30

70.66B ± 1.32

Total

70.35 ± 1.43

74.85 ± 1.18

74.63 ± 1.30

* Small letters indicate the differences between diagnoses. Capital letters indicate the differences between the sexes.
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Table 3. The result of nonparametric test after Bonferroni-Dunn.
OSAS

OSAS

Men
Women

OSAS

Men
Women

OSAS

Men
Women

OSAS

Women

OSAS

Women

OSAS

Men
Women

Moderate

Severe

Mild

1.00000

*

*

22.7

Moderate

0.09384

1.00000

*

33.3

Severe

0.00008

0.01198

1

47.5

Mild

1.00000

0.28387

*

13.3

*

1.00000

*

9.7

Severe

0.77177

0.42339

1

12.3

Mild

1.00000

*

*

55.5

Moderate

0.00225

1.00000

*

36.2

Severe

0.00000

0.01861

1

22.9

Mild

1.00000

0.06496

*

17.9

*

1.00000

*

11.6

Severe

0.00083

0.07819

1

5.9

Mild

1.00000

*

*

19.3

Moderate

0.03486

1.00000

*

32.3

Severe

0.00000

0.00087

1

50.7

Mild

0.66656

1.00000

*

8.2

Moderate

0.00000

*

*

9.6

Severe

0.01784

0.01065

1

16.9

Mild

1.00000

*

*

43.9

Moderate

0.36440

1.00000

*

38.2

Severe

0.01383

0.08654

1

28.6

Mild

0.55480

1.00000

*

11.7

Moderate

1.00000

*

*

9.7

Severe

0.21130

0.56678

1

13.7

Mild

1.00000

*

*

28.7

Moderate

0.25702

1.00000

*

35.9

Severe

0.05000

0.36511

1

41

Mild

0.53118

1.00000

*

9.6

Moderate

1.00000

*

*

11.7

Severe

0.72822

0.36388

1

12.9

Mild

1.00000

*

*

35.1

Moderate

0.76997

1.00000

*

37.0

Severe

0.92951

0.81938

1

35.7

Mild

0.70881

1.00000

*

10.7

Moderate

1.00000

*

*

11.9

Severe

0.92655

0.78694

1

11.6

Moderate

Men

Height
MSPT
Post. FH

Rank mean

Mild

Moderate

Men

Mean Sa O2 Des.%

Lowest SaO2 %

Arousal index

Variables
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and severe OSAS, the differences were found to be
significant (Mann-Whitney U, P < 0.01 and P < 0.05,
respectively).

routine examinations (17). However, ethnicity
and sex should be considered in the evaluation of
cephalometry.

The difference in the diagnostic rank means was
not significant in the comparison of diagnostic level
means using Kruskal-Wallis for the Post. FH of men
and women. Furthermore, no statistically significant
difference was shown between the rank means of
men and women for Post. FH for mild, moderate, or
severe OSAS.

It was reported that the collapse mechanism of UA
in men and women is different and related to local
anatomical differences (18). There are obvious sex
differences in the craniofacial skeletal characteristics
that contribute to OSAS severity and, to evaluate OSAS
severity, different anthropometric and cephalometric
measurements should be used for men and women
(10). In our study, we found statistically significant
differences in some cephalometric measurements
[Go-Gn, ANS-Me, Ant. FH (P < 0.01), Hy-MPPerp
(P < 0.05), PNS-PA (P < 0.001)] between men and
women. However, these measurements were not
valuable in predicting OSAS severity without the sex
factor, but it was found that PNS-PA had an effect on
women in the stepwise regression analysis (R square
67%, P < 0.05).

The correlations between polysomnographic and
demographic data with cephalometric measurements
of sex factors are shown in Table 4.
In the stepwise discriminant analysis, the lowest
SaO2% and mean SaO2 desaturation% parameters
were included in Fisher’s linear discriminant
function. The results obtained from the discriminant
analysis are shown in Table 5a. The total result for this
discrimination was 60.2%. If the diagnosis was made
using parameters other than AHI, the estimated
success of discrimination was 60.2%. The estimated
successes were distributed as follows: mild group
with 83.3%, moderate group with 54.3%, and severe
group with 50% (Table 5b).
In the regression analysis, 2 parameters were
included in the model to estimate AHI: lowest SaO2%
and arousal index. All parameters used to estimate R
square were found to be 72% (P < 0.01), but it was
not statistically significant in predicting the severity
of OSAS.
For the stepwise regression analysis, the mean
SaO2 desaturation, arousal index, BMI, and MAS
were included in the model. The regression equation
was found to be AHI = 44.904 +4.171/mean SaO2
desaturation +0.524/arousal index + 0.978 BMI +
1.331 MAS. The R square found by the regression
equation was 67% and was statistically significant (P
< 0.01). The included variables varied according to
sex: mean SaO2 and neck circumference (R square
61%, P < 0.001) in men and mean SaO2 and PNS-PA
(R square 67%, P < 0.05) in women.
Discussion
Cephalometric analysis is a valuable tool for the
diagnosis of OSAS and should be considered among
994

Tsai et al. (10) stated that BMI increased with
the severity of OSAS in both sexes. In our study, the
difference in BMI between men and women varied
according to the severity of OSAS, but the changes in
the BMI of women were different from those of men.
The level of BMI in women did not increase with the
severity of OSAS. Obesity has been thought to be a
primary cause of OSAS, but not all obese patients
have OSAS. Pae et al. (19,20) stated that face type in
some non-obese patients had a significant role in the
diagnosis of OSAS. Although the BMI of women did
not increase according to the severity of OSAS, there
were differences in the face types of women in our
study. Face divergence increased with the severity of
OSAS. However, anterior face height measurements
correlated with the severity of OSAS in men. In
addition, a greater lower facial height was also related
to an overall increase in OSAS severity in men.
The measurements of neck circumference were
significantly different between men and women.
They increased with the increase in AHI in both
sexes. However, we found no differences for waist
circumferences in either sex or for the severity of
OSAS. Ryan et al. (21) showed that obese patients
with large necks tend to have a more easily collapsible
velopharynx during wakefulness. Obesity, through
fat deposits around the upper airway in the neck,
might narrow the pharynx and alter its shape and

Women

Men

Sex factors

–0.342

–0.345

–0.397

Arousal index

Awake SaO2%

Lowest SaO2

0.350

0.327

AHI

ESS

0.410**

ESS

0.392

0.059

0.187

WC

WC

–0.110

0.322**

NC

0.004

–0.184

0.246*

BMI

NC

–0.253*

0.310**

MeanSaO2 Des.

0.255

–0.235*

–0.282*

Lowest SaO2

BMI

0.099

–0.138

Awake SaO2%

0.287

–0.046

0.279*

Arousal index

MeanSaO2 Des.

–0.249*

0.410**

AHI

0.211
0.312

–0.482*

–0.110

0.059

0.168

–0.198

0.030

0.181

0.252

0.222

0.167

0.313**

0.193

0.154

–0.121

–0.140

0.161

0.302*

MAS

–0.185

–0.328

–0.187

–0.250

0.269

–0.158

0.205

–0.353

–0.113

SAS

IAS

Parameters

0.039

0.181

0.344

0.269

0.005

–0.082

0.157

–0.145

0.192

0.223

0.178

0.289*

0.223

0.304**

–0.225

–0.149

0.286*

0.337**

MSPT

–0.354

0.296

–0.014

–0.166

0.025

–0.066

0.210

0.084

0.316

–0.053

0.119

–0.054

0.098

0.327**

–0.264*

–0.090

0.296*

0.163

SNGoGn°

–0.172

0.178

–0.067

–0.043

–0.224

–0.035

0.323

0.031

–0.115

0.084

0.430*
–0.429*

–0.152

–0.120

0.018

0.58

–0.083

–0.082

–0.147

–0.034

–0.041

0.089

0.112

–0.092

ANB°

0.099

–0.125

–0.245

0.217

0.057

0.103

0.129

0.001

–0.085

–0.225

–0.007

0.052

Go-Gn

–0.379

–0.152

0.161

–0.054

–0.298

0.183

0.136

–0.329

–0.073

0.381

0.127

0.083

0.008

0.221

–0.127

0.073

0.262

0.030

0.140

–0.066

0.285*
0.043

0.022

0.086

0.049

0.301*

0.303*

0.378**

0.034

0.097

–0.235*
–0.339**

–0.009

0.066

Post. FH

0.333**

0.393**

Ant. FH

Cephalometric measurements

0.463

0.259

0.419

0.269

0.528*

–0.410

–0.030

0.083

0.359

0.299*

0.218

0.129

0.105

0.351**

–0.288*

–0.087

0.090

0.302*

Hy-MPPerp

–0.167

–0.061

–0.043

0.025

–0.115

0.165

–0.141

–0.251

–0.385

0.129

–0.010

–0.002

–0.038

0.076

–0.012

–0.225

–0.046

0.037

PNS-PA

–0.118

–0.080

0.115

0.103

–0.298

0.072

–0.183

–0.558**

–0.202

0.008

0.195

0.262*

0.210

0.249*

–0.262*

–0.150

0.125

0.231

ANS-Me

Table 4. The correlations between polsomnographic and demographic data with cephalometric measurements due to sex factors. (*P < 0.005. **P < 0.001)
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Table 5a. The result of discriminant analysis.
OSAS severity
Mild

Moderate

Severe

Lowest SaO2 %

3.964

3.787

3.802

Mean SaO2 Des. %”

8.313

8.084

8.557

–187.667

–172.061

–176.448

(Constant)

Fisher’s linear discriminant functions

Table 5b. The distribution of estimated success according to the severity of OSAS.
Predicted group membership
Diagnosis

n

%

Total
Mild OSAS

Moderate OSAS

Severe OSAS

Mild OSAS

20

4

0

24

Moderate OSAS

11

19

5

35

Severe OSAS

5

12

17

34

Mild OSAS

83.3

16.7

0.0

100.0

Moderate OSAS

31.4

54.3

14.3

100.0

Severe OSAS

14.7

35.3

50.0

100.0

60.2% of original grouped cases correctly classified.

mechanical properties, predisposing patients to
sleep-related obstruction (21). Although neck and
waist circumferences correlated with BMI in our
study, upper airway space (IAS, MAS) measurements
increased and correlated positively with neck
circumferences. Maximum soft palate thickness
increased in our patients with the increase in neck
circumference and correlated with the severity of
OSAS.

in soft palate thickness and pharyngeal wall fat
deposits. The most important finding obtained with
cephalometry in apnea patients is the reduction
in the velopharyngeal space (22). We found that
SAS measurements increased in patients with long
uvulas. This may be associated with conducting the
cephalometric radiology in an upright position.
Furthermore, we found no relationship between
uvula length and severity of OSAS in our study.

In our study, the mean levels of IAS and SAS
were not statistically different for sex, but in
the variance analysis these measurements were
statistically significant for the severity of OSAS. SAS
measurements correlated negatively with AHI, BMI,
MSPT, and Post. FH. We assume that the decrease
in SAS measurements is associated with the increase

The position of the hyoid bone becomes more
inferior as the condition becomes more severe (8), as
found in our study. The hyoid bone was located inferior
in men with smaller mandibular body length, but this
was not seen in women. The hyoid bone’s inferior
location in women was more closely associated with
BMI in women than in men (mean BMI: 32.87 >
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30), but it was not related to the mandibular body
length. Tangugsorn et al. (23) found a significantly
lower position of the hyoid bone in obese patients.
The cause of an inferiorly located hyoid bone may be
diffuse fat deposits due to obesity or small mandibular
body length. Contrary to the findings of Pae et al. (20),
there was no relationship between the face type and
the hyoid position in our study. However, anterior
face height was associated with the severity of OSAS
in obese and non-obese patients.
We found correlations (positive and negative)
between AHI and some cephalometric measurements.
It is interesting that most of these correlations were
found in men. These measurements increased with the
severity of OSAS. These findings were also supported
by the other parameters of the polysomnographic
data. We documented the fact that mandibular body
length was important in predicting the severity of
OSAS. Although it was not significant, a gradual
decrease in mandibular body length was seen with
increased severity of OSAS. The lowest oxygen
saturation measured during the polysomnography
correlated positively with mandibular body length.
Mean oxygen desaturation correlated positively
with hyoid bone position, which increased with the
severity of OSAS in women. We found no correlation
between demographic parameters and cephalometric
parameters in women. OSAS is more common in
men than in women, despite the fact that women
with OSAS tend to be more obese and have smaller
upper airways than men (24). We also noted this sex
difference in our study, and men had significantly
higher AHI than women, although the BMI value
was greater in women. However, BMI played a
significant role and correlated with cephalometric
measurements in men.
The ESS is a self-administered questionnaire
measuring the subject’s general level of daytime
sleepiness (25). Although ESS is a subjective test,
it was found to correlate with AHI. However, there
was no correlation with BMI and cephalometric
measurements except for Hy-MPPerp in both sexes.
In the discriminant analysis, 2 polysomnographic
data points were effective in estimating the diagnosis
with 60.2% accuracy. In the regression analysis, we
needed all parameters to estimate the diagnosis with
72% accuracy. When we used stepwise regression,

we had 4 parameters to estimate the diagnosis with
67% accuracy. The only cephalometric measurement
in this model was MAS, and we found that MAS
increased due to the severity of OSAS in our study.
The upper airway was found to be narrow in patients
with severe OSAS. The upper airway shows anatomic
differences during awake and sleep periods, and an
occlusion occurs at different levels along the upper
airway in patients with OSAS (26). The obstruction
begins with fat deposits on the lateral pharyngeal
wall, where it cannot be seen in cephalometric
graphs. The purpose of this study was not to define
the level of obstruction but to examine the changes
related to the OSAS.
The limitations of our study included the fact that
we performed the cephalometric examinations on
patients in an awake state and an upright position.
However, upper airway resistance increases during
sleeping in normal subjects and patients with OSAS
(27). The cephalometric graphs were taken at the end
of expiration. Schwab et al. (27) demonstrated that
airway caliber is the smallest at the end of expiration
in normal and OSAS subjects. Previous studies
have also revealed that the upper airway is smaller
during certain phases of the respiratory cycle, and
the difference is more significant during sleep (28).
The group of women was small in our study. We
assumed that this may be the reason for the failure
to show a correlation between cephalometric and
polysomnographic parameters. We need further
studies with larger groups with different ethnic
backgrounds, sexes, and ages to examine the
cephalometric graphs.
In conclusion, this study evaluated the
cephalometric measurements with polysomnographic
and demographic parameters to predict the severity
of OSAS. The changes in oxygen saturation correlated
with AHI may be used to evaluate the cephalometric
measurements. The cephalometric measurements
are not sufficient to predict the severity of OSAS.
However, the cephalometric measurements with BMI
may give a useful indication of the severity of OSAS.
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